Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Payables: 2022-2024

Historic Payables for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $5.1 million.

  • Orchestra BioMed Holdings' Payables rose 79.40% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.5 million, marking a year-over-year increase of 41.90%. This contributed to the annual value of $5.1 million for FY2024, which is 77.03% up from last year.
  • Orchestra BioMed Holdings' Payables amounted to $5.1 million in FY2024, which was up 77.03% from $2.9 million recorded in FY2023.
  • Orchestra BioMed Holdings' Payables' 5-year high stood at $5.1 million during FY2024, with a 5-year trough of $2.9 million in FY2023.
  • Over the past 3 years, Orchestra BioMed Holdings' median Payables value was $4.0 million (recorded in 2022), while the average stood at $4.0 million.
  • As far as peak fluctuations go, Orchestra BioMed Holdings' Payables fell by 26.92% in 2023, and later skyrocketed by 77.03% in 2024.
  • Orchestra BioMed Holdings' Payables (Yearly) stood at $4.0 million in 2022, then declined by 26.92% to $2.9 million in 2023, then surged by 77.03% to $5.1 million in 2024.